Why Teva stock isn’t moving on its major Huntington’s disease drug approval
April 04, 2017 at 16:47 PM EDT
For once, it seems to have nothing to do with price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.